title: Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
authors.forename: W G
authors.initials: WG
authors.lastname: Peters
authors.forename: R
authors.initials: R
authors.lastname: Willemze
authors.forename: L P
authors.initials: LP
authors.lastname: Colly
authors.forename: H F
authors.initials: HF
authors.lastname: Guiot
mesh_terms: D000328:Adult; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D003561:Cytarabine